MINI FUTURE LONG - VIRBAC | Real-time Euronext Paris 06:47:16 2024-05-13 EDT | ||
| 1.395 EUR | -2.45% |
|
| Current month | +6.72% | ||
| 1 month | +2.14% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
VIRBAC
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-13 | 1.395 | -2.45% | 8 |
| 24-05-10 | 1.43 | 0.00% | 12 |
| 24-05-09 | 1.43 | 0.00% | 13 |
| 24-05-08 | 1.43 | +5.93% | 23 |
| 24-05-07 | 1.35 | -4.26% | 19 |
Real-time Euronext Paris
Last update May 13, 2024 at 06:47 am
More quotesStatic data
| Product type | Certificat Turbo Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | VIRBAC |
| Issuer | 
BNP Paribas
|
| HS3IB | |
| ISIN | FRBNPP04UNB2 |
| Date issued | 2022-09-27 |
| Strike | 217.1 € |
| Maturity | Unlimited |
| Parity | 100 : 1 |
| Emission price | 0.67 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.635 € |
|---|---|
| Lowest since issue | 0.255 € |
| Spread | 0.01 € |
| Spread % | 0.72% |
Company Profile
Virbac specializes in the research, production and marketing of veterinary medicines. The activity is organized around 2 product families:
- pet medications: pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips;
- livestock medications: pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc.
Net sales are distributed geographically as follows: France (15.4%), Europe (26.2%), Latin America (17.1%), Asia (16.4%), North America (13.2%), Pacific (9.3%), Africa and Middle East (2.4%).
Sector
-
Consensus: Virbac
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
357
EUR
Average target price
368
EUR
Spread / Average Target
+3.08%
- Stock Market
- Certificates
- HS3IB Certificat